187 related articles for article (PubMed ID: 11588854)
1. Hormones and prostate cancer: what's next?
Hsing AW
Epidemiol Rev; 2001; 23(1):42-58. PubMed ID: 11588854
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor signaling in androgen-refractory prostate cancer.
Grossmann ME; Huang H; Tindall DJ
J Natl Cancer Inst; 2001 Nov; 93(22):1687-97. PubMed ID: 11717329
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor action in hormone-dependent and recurrent prostate cancer.
Agoulnik IU; Weigel NL
J Cell Biochem; 2006 Oct; 99(2):362-72. PubMed ID: 16619264
[TBL] [Abstract][Full Text] [Related]
4. Molecular regulation of androgen action in prostate cancer.
Dehm SM; Tindall DJ
J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832
[TBL] [Abstract][Full Text] [Related]
5. Molecular action of androgen in the normal and neoplastic prostate.
Kokontis JM; Liao S
Vitam Horm; 1999; 55():219-307. PubMed ID: 9949683
[No Abstract] [Full Text] [Related]
6. The importance of steroid hormones in prostate cancer.
Wilding G
Cancer Surv; 1992; 14():113-30. PubMed ID: 1423327
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault.
Arnold JT; Isaacs JT
Endocr Relat Cancer; 2002 Mar; 9(1):61-73. PubMed ID: 11914183
[TBL] [Abstract][Full Text] [Related]
8. Androgen regulation of micro-RNAs in prostate cancer.
Waltering KK; Porkka KP; Jalava SE; Urbanucci A; Kohonen PJ; Latonen LM; Kallioniemi OP; Jenster G; Visakorpi T
Prostate; 2011 May; 71(6):604-14. PubMed ID: 20945501
[TBL] [Abstract][Full Text] [Related]
9. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
Vis AN; Schröder FH
BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
[TBL] [Abstract][Full Text] [Related]
10. Markers of androgen-independent progression of prostatic carcinoma.
Daliani D; Papandreou CN
Semin Oncol; 1999 Aug; 26(4):399-406. PubMed ID: 10482182
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms in hormone-resistant prostate cancer.
Roznovanu SL; Amălinci C; Rădulescu D
Rev Med Chir Soc Med Nat Iasi; 2005; 109(3):577-83. PubMed ID: 16607754
[TBL] [Abstract][Full Text] [Related]
12. [Molecular mechanisms involved in hormone resistance of prostate cancer].
Cabrespine A; Guy L; Chollet P; Debiton E; Bay JO
Bull Cancer; 2004 Oct; 91(10):747-57. PubMed ID: 15556875
[TBL] [Abstract][Full Text] [Related]
13. [Hormone receptors and growth factors in carcinoma of the prostate].
Sica G; Lama G; Angelucci C; Zelano G
Arch Ital Urol Androl; 1997 Sep; 69(4):247-52. PubMed ID: 9417297
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of androgen-refractory prostate cancer.
Debes JD; Tindall DJ
N Engl J Med; 2004 Oct; 351(15):1488-90. PubMed ID: 15470210
[No Abstract] [Full Text] [Related]
15. Androgen-regulated gene expression in prostate cancer.
Trapman J; Cleutjens KB
Semin Cancer Biol; 1997 Feb; 8(1):29-36. PubMed ID: 9299579
[TBL] [Abstract][Full Text] [Related]
16. [Androgen-dependent tumor].
Shimazaki J; Furuya Y; Sato N; Ichikawa T
Nihon Naibunpi Gakkai Zasshi; 1993 Jan; 69(1):16-24. PubMed ID: 8449242
[TBL] [Abstract][Full Text] [Related]
17. Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line.
Watson PA; Ellwood-Yen K; King JC; Wongvipat J; Lebeau MM; Sawyers CL
Cancer Res; 2005 Dec; 65(24):11565-71. PubMed ID: 16357166
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of loss of androgen dependency in androgen-dependent tumor].
Sato N; Suzuki H; Shimazaki J
Hum Cell; 1993 Sep; 6(3):170-5. PubMed ID: 8297812
[TBL] [Abstract][Full Text] [Related]
19. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility.
Ross RK; Pike MC; Coetzee GA; Reichardt JK; Yu MC; Feigelson H; Stanczyk FZ; Kolonel LN; Henderson BE
Cancer Res; 1998 Oct; 58(20):4497-504. PubMed ID: 9788589
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor and prostate cancer: molecular aspects and gene expression profiling.
Sommer A; Haendler B
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):702-11. PubMed ID: 14579520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
